
|
PXE Awareness |
|
Volume 14, Issue 1. April 2008 |
Global
Pseudoxanthoma Elasticum Foundation
By Rashmin Gandhi, MD
Dr. Gandhi,
a cataract specialist, met with NAPE for its Atlanta conference. Those present will recall
conversations with him about PXE and other vision issues. Following is the text
of Dr. Gandhi’s report. Global PXE Foundation
(GPF) For Clinical Care And
Research GPF is a
non-profit global organization committed to enhancing the awareness, clinical
care, and research toward helping PXE patients worldwide. Our
mission is to bring together expertise and influence of eminent individuals
within the private and public sector domain to work synergistically for the
common good of PXE patients. ROLES
·
Foster educational activities, basic science/clinical research and care toward
helping
·
P
·
Create and maintain a database comprised of symptoms, diagnostic tools,
treatment
·
Disseminate scientific knowledge about PXE through symposia, publications and
other
·
Assist PXE associations at regional, national and international levels in
identification of
·
Create awareness within public and private sectors about PXE
·
Help policy makers globally to invest resources for developing new clinical
modalities
·
Establish consortia incorporating active clinical and basic sciences research
groups
SCHOLARSHIP GPF will
provide scholarship and training activities for medical students/scientists with
interests in PXE clinical and basic sciences research every year.
Scholarship name will be decided by the Board of GPF. ANNUAL
AWARD GPF will
administer an annual award recognizing excellence in clinical care and basic
sciences research that directly impact care and treatment of PXE patients.
Annual
award name will be decided by the Board of GPF.
click to listen ( 532 KB AUDIO SIZE )
Editor’s Note: Dr. Rashmin Gandhi spoke on behalf of
Sankara Nethralaya at the program on January 9 in Chennai, India,
announcing the Global Pseudoxanthoma Elasticum Foundation. The purpose of this foundation is to support the
Pseudoxanthoma Elasticum research program initiated at Sankara Nethralaya. This
eye care center has identified in its records over 170 patients who have PXE.
These patients will be contacted for possible genetic study and counseling. As
well, patients identified currently and in the future who present angioid
streaks will be tested for PXE, and if so identified, they will be invited to
participate in the study and will receive counseling regarding the inheritance
and care for this disorder. These patients will be followed for as long as they
need help, and the results of the study will provide information to be used by the genetics team at Sankara Nethralaya in collaboration
with Dr. Berthold Struk.

Dr. Rashmin Gandhi
the PXE patient population worldwide.
available diagnostic and treatment options.
options, and clinical outcomes of PXE patients worldwide
electronic and print media
various treatment options for the care and well being of PXE
patients
and treatment options

Back to Table of Contents
Home |
Current Article |
What is PXE? |
Contact NAPE |
Membership Form |
PXE Pals |
Q & A |
Amsler Grid